1. Allender, S, Peto, V, Scarborough, P, Boxer, A & Rayner, M (2007) Coronary Heart Disease Statistics. London: BHF.
2. Vander, A, Sherman, J & Luciano, D (1998) Human Physiology: The Mechanisms of Body Function, 7th ed., pp. 444–448. Columbus, OH: McGraw-Hill.
3. Guyton, AC & Hall, JE (2006) Textbook of Medical Physiology, 9th ed., pp. 252–253. Philadelphia, PA: Elsevier Inc.
4. De Backer, G, Ambrosionie, E, Borch-Johnsen, K et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24, 1601–1610.
6. Brat, P, Georgé, S, Bellamy, A, Du Chaffaut, L, Scalbert, A, Mennen, L, Arnault, N & Amiot, MJ (2006) Daily polyphenol intake in France from fruit and vegetables. J Nutr 136, 2368–2373.
7. Hertog, MG, Feskens, EJ & Kromhout, D (1997) Antioxidant flavonols and coronary heart disease risk. Lancet 349, 699.
8. Zhao, B, Guo, Q & Xin, W (2001) Free radical scavenging by green tea polyphenols. In Flavonoids and Other Polyphenols. Methods in Enzymology, vol. 335, pp. 217–231 [Packer, L and Sies, H, editors]. London: Academic Press.
9. Manach, C, Mazur, A & Scalbert, A (2005) Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16, 77–84.
10. Muntwyler, J, Hennekens, CH, Manson, JE, Buring, JE & Gaziano, JM (2002) Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Int Med 162, 1472–1476.
11. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360, 23–33.
12. Hakkinen, S (2000) Flavonols and phenolic acids in berries. PhD Thesis, Kuopio University, Finland.
13. Dey, PM & Harborne, JB (editors) (1989) Methods in Plant Biochemistry, vol. 1: Plant Phenolics, p. 3. London: Academic Press.
14. Manach, C, Scalbert, A, Morand, C, Remesy, C & Jimenez, L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727–747.
15. Signorelli, P & Ghidoni, R (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16, 449–466.
16. Yance, DR & Sagar, SM (2006) Targeting angiogenesis with integrative cancer therapies. Integrative Cancer Therapies 5, 9–29.
17. Shoskes, DA, Zeitlin, SI, Shahed, A & Rajfer, J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double blind, placebo-controlled trial. Urology 54, 960–963.
18. Lee, YS (2005) Role of NADPH oxidase-mediated generation of reactive oxygen species in the mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells. Arch Pharm Res 28, 1183–1189.
19. Sudheer, A, Muthukumaran, S, Kalpana, C, Srinivasan, M & Menon, VP (2007) Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: A comparison with N-acetylcysteine. Toxicol In Vitro 21, 576–585.
20. Guo, S, Yang, S, Taylor, C & Sonenshein, GE (2005) Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene. J Nutr 135, 2978S–2986S.
21. Borska, S, Gebarowska, E, Wysocka, T, Drag-Zalesińska, M & Zabel, M (2003) Induction of apoptosis by EGCG in selected tumour cell lines in vitro. Folia Histochem Cytobiol 41, 229–232.
22. Tosetti, F, Ferrari, N, De Flora, S & Albini, A (2002) Angioprevention: angiogenesis is a common and key target for cancer chemoprevention. FASEB Journal 16, 2–14.
23. Zern, TL and Fernandez, ML (2005) Cardioprotective effects of dietary polyphenols. J Nutr 135, 2291–2294.
24. Klabunde, RE (2005) Cardiovascular Physiology Concepts. Philadelphia, PA: Lippencott, Williams and Wilkins.
25. Vickers, J (1995) Endothelial cells and platelet function. PhD Thesis, University of Nottingham.
26. Fox, SI (2004) Human Physiology, 9th ed. Maidenhead, Berks.: McGraw-Hill Higher Education.
27. Levick, JR (editor) (2004) An Introduction to Cardiovascular Physiology, 4th ed., pp. 131–132. London: Arnold Publishing.
28. Sherwood, L (2003) Fundamentals of Physiology; A Human Perspective, 3rd ed. London: Thomson, Brooks, Cole.
29. Ambra, R, Rimbach, G, de Pascual Teresa, S, Fuchs, D, Wenzel, U, Daniel, H & Virgili, F (2006) Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells. Nutr Metab Cardiovasc Dis 16, 35–43.
30. Oak, MH, Chataigneau, M, Keravis, T, Chataigneau, T, Beretz, A, Andriantsitohaina, R, Stoclet, JC, Chang, SJ & Schini-Kerth, VB (2003) Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol 23, 1001–1007.
31. Wallerath, T, Li, H, Godtel-Ambrust, U, Schwarz, PM & Forstermann, U (2005) A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12, 97–104.
32. Fagan, KA, McMurthy, IF & Rodman, DM (2001) Role of endothelin-1 in lung disease. Respir Res 2, 90–101.
33. Diebolt, M, Bucher, B & Andriantsitohaina, R (2001) Wine polyphenols decrease blood pressure, improve NO vasodilation, and induce gene expression. Hypertension 38, 159–165.
34. Noé, V, Peñuelas, S, Lamuela-Raventós, RM, Permanyer, J, Ciudad, CJ & Izquierdo-Pulido, M (2004) Epicatechin and a Cocoa Polyphenolic Extract Modulate Gene Expression in Human Caco-2 Cells. J Nutr 134, 2509–2516.
35. Iijima, K, Yoshizumi, M & Ouchi, Y (2003) Effects of red wine polyphenols on vascular smooth muscle cells function-molecular mechanisms of the ‘French paradox’. Mech Ageing Dev 123, 1033–1039.
36. Walle, T, Hsieh, F, DeLegge, MH, Oatis, JE & Walle, UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377–1382.
37. Wallerath, T, Poleo, D, Li, H & Forstermann, U (2003) Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 41, 471–478.
38. Corder, R, Douthwaite, JA, Lees, DM, Khan, NQ, Viseu Dos Santos, AC, Wood, EG & Carrier, MJ (2001) Health: Endothelin-1 synthesis reduced by red wine. Nature 414, 863–864.
39. Liu, JC, Chen, JJ, Chan, P, Cheng, CF & Cheng, TH (2003) Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42, 1198–1205.
40. Chao, HH, Juan, SH, Liu, JC, Yang, HY, Yang, E, Cheng, TH & Shyu, KG (2005) Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur J Pharmacol 515, 1–9.